Immix Biopharma Announces Additional NXC-201 AL Amyloidosis
LOS ANGELES, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us”), a clinical-stage biopharmaceutical company...
Stay updated with breaking news from Presentation Details. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LOS ANGELES, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us”), a clinical-stage biopharmaceutical company...
LOS ANGELES, Aug. 16, 2023 -- Immix Biopharma, Inc. , a clinical-stage biopharmaceutical company pioneering personalized therapies for oncology and immunology, today announced that additional... -Today at 09:06 am- MarketScreener
NEW YORK & TEL AVIV, Israel, August 14, 2023--monday.com (NASDAQ: MNDY), a work operating system (Work OS) where organizations of any size can create the tools and processes they need to manage every aspect of their work, today reported financial results for its second quarter ended June 30, 2023.
Second quarter revenue of $175.7 million grew 42% year over year Number of customers with more than $50k ARR grew 63% year over year Successfully completed and released mondayDB 1.0 Launched... -Today at 07:06 am- MarketScreener
CINCINNATI, July 13, 2023 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware...